Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06635785
What this trial is testing

Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
OncoC4, Inc. 387
Testing effectiveness (Phase 2)Looking for participantsNCT06878625
What this trial is testing

A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer

Who this might be right for
Evaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 138
Large-scale testing (Phase 3)Study completedNCT03357952
What this trial is testing

JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 10
Testing effectiveness (Phase 2)UnknownNCT05186558
What this trial is testing

Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL

Who this might be right for
Lymphoma, Large B-Cell, DiffuseNeoplasms by Histologic Type
The First Affiliated Hospital with Nanjing Medical University 54
Testing effectiveness (Phase 2)Study completedNCT04122625
What this trial is testing

Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143

Who this might be right for
Solid Tumor
Debiopharm International SA 46
Early research (Phase 1)Study completedNCT02742935
What this trial is testing

Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects

Who this might be right for
Solid TumorBreast CancerGastrointestinal Cancer
Jiangsu HengRui Medicine Co., Ltd. 99
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741617
What this trial is testing

A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma

Who this might be right for
Urologic Neoplasms
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 54
Testing effectiveness (Phase 2)Looking for participantsNCT06475300
What this trial is testing

BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerNasopharyngeal CarcinomaSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 570
Very early researchUnknownNCT04690036
What this trial is testing

PD-1 Antibody for Reactive EBV After BMT

Who this might be right for
PD-1EBV InfectionTransplant
Beijing Friendship Hospital 20
Early research (Phase 1)UnknownNCT05019534
What this trial is testing

Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer

Who this might be right for
BRAF V600E-mutated /MSS Metastatic Colorectal CancerVemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal Antibody
West China Hospital 12
Early research (Phase 1)Not Yet RecruitingNCT07619001
What this trial is testing

Evaluate the PK Similarity of AK104 in Healthy Chinese Male Participations

Who this might be right for
Healthy Male Adults Participants
Akeso 158
Testing effectiveness (Phase 2)Study completedNCT03852251
What this trial is testing

AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaAdvanced Solid TumorsGastroesophageal Junction Adenocarcinoma
Akeso 338
Testing effectiveness (Phase 2)UnknownNCT05402722
What this trial is testing

Study of Eribulin in Combination With Anti-PD-1 Antibody in Patients With Metastatic Triple-Negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Beijing 302 Hospital 30
Very early researchLooking for participantsNCT06928922
What this trial is testing

Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.

Who this might be right for
Advanced Lung CancerLung Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 83
Testing effectiveness (Phase 2)Study completedNCT03796429
What this trial is testing

The Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Shanghai Zhongshan Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06969027
What this trial is testing

JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 69
Testing effectiveness (Phase 2)Ended earlyNCT03632941
What this trial is testing

Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer

Who this might be right for
Breast CancerHER2+ Breast Cancer
Herbert Lyerly 8
Testing effectiveness (Phase 2)Study completedNCT03469557
What this trial is testing

BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma
BeiGene 30
Testing effectiveness (Phase 2)UnknownNCT04273100
What this trial is testing

PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Tianjin Medical University Cancer Institute and Hospital 56
Not applicableUnknownNCT06281912
What this trial is testing

Impact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma Patients

Who this might be right for
Early MelanomaAdvanced Melanoma
Azienda Ospedaliera di Perugia 70
Next Page